Skip to main content
Log in

Unusual clinical manifestation of pheochromocytoma in a MEN2A patient

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A case of unusual clinical manifestation of pheochromocytoma in a type 2A multiple endocrine neoplasia (MEN2A) patient is presented. A 27-year-old man affected by MEN2A syndrome, complaining of anxiety and depression, was admitted in our Division. Past medical history included a total thyroidectomy for medullary carcinoma in 1985, and left adrenalectomy for pheochromocytoma in 1994. Blood pressure was 130/85 mmHg without orthostatic hypotension and pulse rate was 72 beats/min. Laboratory data revealed thyroid hormones and carcinoembryonic antigen (CEA) in the normal range and high basal serum calcitonin levels (158 pg/ml). Plasma catecholamines and vanillylmandelic acid resulted in normal levels but epinephrine/norepinephrine ratio was elevated (0.65). The glucagon stimulation test showed positive clinical and biochemical response. Magnetic resonance imaging (MRI) and meta-iodobenzylguanidine (MIBG) scintiscan confirmed the presence of bilateral adrenal masses. Bilateral adrenalectomy by laparoscopic anterior approach was performed. Histology was consistent with adrenal pheochromocytomas. After surgical approach, psychiatric findings disappeared and did not recur at follow-up in spite of no medication for two years. In conclusion, bilateral pheochromocytoma is more frequent in MEN2A syndrome and probably understimated if the follow-up is not prolonged. In these cases clinical features are often aspecific and basal hormonal data may be normal in a great number of patients. Therefore long-term observation is justified in these patients. Pheochromocytoma was described as the “great mimic” for the numerous subjective manifestations. Differential diagnosis among typical features of neuropsychiatric disorders and pheochromocytoma must be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bouloux P.G., Fakeeh M. Investigation of pheochromocytoma. Clin. Endocrinol. (Oxf.) 1995, 43: 657–664.

    Article  CAS  Google Scholar 

  2. Gagel R.F., Tashjan A.H., Cummings T., Papathanasopoulos N., Kaplan M., DeLellis R.A., Wolfe H.J., Reichlin S. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2A. N. Engl. J. Med. 1988, 318: 478–484.

    Article  CAS  PubMed  Google Scholar 

  3. Gagner M. Laparoscopic adrenalectomy. Surg. Clin. North Am. 1996, 76: 3, 523–537.

    Article  CAS  PubMed  Google Scholar 

  4. Filipponi S., Guerrieri M., Arnaldi G., Giovagnetti M., Masini A.M., Lezoche E., Mantero F. Laparoscopic adrenalectomy: a report on 50 operations. Eur. J. Endocrinol. 1998, 138: 548–553.

    Article  CAS  PubMed  Google Scholar 

  5. Bonnin F., Schlumberger M., Gardet P., Tenembaum F., Lumbroso J., Leclere J., Comoy E., Megnigbeto A., Travagli J.P., Parmentier C. Screening for adrenal medullary disease in patients with medullary thyroid carcinoma. J. Endocrinol. Invest. 1994, 17: 253–257.

    Article  CAS  PubMed  Google Scholar 

  6. Evans D.B., Lee J.E., Merrell R.C., Hickey R.C. Adrenal medullary disease in multiple endocrine neoplasia type 2. Appropriate management. Endocrinol. Metab. Clin. North Am. 1994, 23: 167–176.

    CAS  PubMed  Google Scholar 

  7. Grossman E., Goldstein D.S., Hoffman A., Keiser H.R. Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 1991, 17: 733–741.

    Article  CAS  PubMed  Google Scholar 

  8. El-Matri A., Slim R., Smerli S., Ayed H.B. Pheochromocytome avec troubles psychiatriques. Un cas. Nouv. Presse Med. 1978, 7: 1467–1470.

    CAS  Google Scholar 

  9. Goldenberg M. Pheochromocytoma and essential hypertensive vascular disease. Arch. Intern. Med. 1950, 86: 823–836.

    Article  CAS  Google Scholar 

  10. Aquilar-Parada E., Rivadeneyra J., Torres-Leon A.G., Serrano P.A. Pseudopheochromocytoma. J.A.M.A. 1971, 218: 884–885.

    Article  Google Scholar 

  11. Lefebvre H., Noblet C., Moore N., Wolf L.M. Pseudo-pheochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline. Clin. Endocrinol. (Oxf.) 1995, 42: 95–98.

    Article  CAS  Google Scholar 

  12. Duarte J., Sempere A.P., Cabezas C., Calvo T., Claveria L.E. Pseudo-pheochromocytoma in a patient with Parkinson’s disease. Ann. Pharmacother. 1996, 30: 546.

    CAS  PubMed  Google Scholar 

  13. Bravo E.L. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr. Rev. 1994, 15: 356–368.

    Article  CAS  PubMed  Google Scholar 

  14. Chakravorty S.G., De Souza C.J., Doongaji D.R. A psychiatric evaluation of referred cancer and medical patients: a comparative study. Indian J. Cancer 1993, 30: 55–60.

    CAS  PubMed  Google Scholar 

  15. Berard R.M., Boermeester F. Psychiatric syntomatology in adolescents with cancer. Pediatr. Hematol. Oncol. 1998, 15: 211–214.

    Article  CAS  PubMed  Google Scholar 

  16. Holland J.C., Mastrovito R. Psychologic adaptation to brest cancer. Cancer 1980, 46 (Suppl. 4): 1045–1052.

    Article  CAS  PubMed  Google Scholar 

  17. Meurisse M., Joris J., Hamoir E., Hubert B., Charlier C. Laparoscopic removal of pheochromocytoma. Why? When? And Who? (Reflections on one case report). Surg. Endosc. 1995, 9: 431–436.

    CAS  PubMed  Google Scholar 

  18. Moley J.F. Medullary thyroid cancer. Surg. Clin. North Am. 1995, 75: 405–420.

    CAS  PubMed  Google Scholar 

  19. Murat A., GETC (Group d’Etude des Tumeurs a Calcitonine). Delection des lesions residuelles et des metastases du cancer medullaire de la thyroide. Ann. Endocrinol. (Paris) 1996, 57: 27–32.

    CAS  Google Scholar 

  20. Tisell L.E., Dilley W.G., Wells S.A. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 1996, 119: 34–39.

    Article  CAS  PubMed  Google Scholar 

  21. Calender A., Giraud S., Schuffenecker I., Lenoir G.M., Gaudray P., Courseaux A., Porchet N., Aubert J.P., Zhang C.X. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia. Horm. Res. 1997, 47: 199–210.

    Article  CAS  PubMed  Google Scholar 

  22. Eisenhofer G., Lenders J.W., Linehan W.M., Walther M.M., Goldstein D.S., Keiser H.R. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N. Engl. J. Med. 1999, 340: 1872–1879.

    Article  CAS  PubMed  Google Scholar 

  23. Gokce O., Gokce C., Gunel S., Arisoy S., Arisoy E., Huseyinoglu K., Kismet K., Ucar O. Pheochromocitoma presenting with headache, panic attacks and jaundice in a child. Headache 1991, 31: 473–475.

    Article  CAS  PubMed  Google Scholar 

  24. Carre A. Panic attack: viewpoint of the internist. Encephale 1996, 5: 11–12.

    Google Scholar 

  25. Lambert M.T. Pheochromocitoma presenting as exacerbation of post traumatic stress disorder symptomology. Int. J. Psychiatry Med. 1992, 22: 265–268.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Guerrieri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guerrieri, M., Filipponi, S., Arnaldi, G. et al. Unusual clinical manifestation of pheochromocytoma in a MEN2A patient. J Endocrinol Invest 25, 53–57 (2002). https://doi.org/10.1007/BF03343961

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343961

Key-words

Navigation